Government urged to delay new GMP system

Published: 2006-08-17 06:57:00

Updated: 2006-08-17 06:57:00

The domestic pharmaceutical industry is calling for the Korea Food and Drug Administration to delay the implementation of a new global good manufacturing practice (GMP) system, while providing an allowance of at least five-year grace period and government support over facility investment, as a si...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK